Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07814014

Real-world Insight Into Systemic Therapies for HCC: Single-center Study

Conditions: HCC - Hepatocellular Carcinoma

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 1000

Sponsor: Mansoura University

Location: Mansoura University Hospitals Al Mansurah Dakahlia Governorate

Summary

Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies

Eligibility Criteria

Inclusion Criteria: * patient with HCC * Child-Pugh class A, B7 * Performance state 0-1 (Eastern Cooperative Oncology Group (ECOG scale). * Barcelona Clinic Liver Cancer (BCLC) stage C or BCLC stage B with diffuse, infiltrative or extensive bilobar involvement or BCLC stage B with tumor progression after TACE. Exclusion Criteria: * patient with other tumor than HCC * Child-Turcotte-Pugh score B (8,9) and C. * Patients eligible for treatment other than systemic therapy according to Barcelona Clinic liver cancer.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07814014). StuddyBuddy aggregates publicly available trial information.